World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
13989
World Ranking
3943
National Ranking
1806

Dennis Panicali publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Dennis Panicali sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 91 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Dennis Panicali D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Dennis Panicali sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 53 D-Index — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Dennis Panicali is affiliated with Harvard University in the United States. The available data does not provide detailed records of research papers, co-authors, or specific publication venues linked to their work.

There are no listed recent papers including titles, years of publication, or venues for Dennis Panicali. Similarly, no frequent co-authors or publication venues are indicated in the records.

The profile does not show information concerning book publications, so it is unclear if Panicali has contributed to academic books or monographs.

No specific main fields or subfields of study are available, nor are there clearly defined main research topics attributed to Dennis Panicali based on the data.

No awards or honors are documented in the provided information.

As current records indicate, Dennis Panicali is living and active in their academic role, though detailed visibility into their research output or scholarly impact is limited based on this data.

Best Publications

  • Importance of the nef gene for maintenance of high virus loads and for development of AIDS.

    Harry W. Kestier;Douglas J. Ringler;Kazuyasu Mori;Dennis L. Panicali

  • Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

    Philip W. Kantoff;Thomas J. Schuetz;Brent A. Blumenstein;L. Michael Glode

  • High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors.

    C Rinaldo;X L Huang;Z F Fan;M Ding

  • Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations.

    H L Robinson;D C Montefiori;R P Johnson;K H Manson

  • Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity

    Dan H. Barouch;Maria G. Pau;Jerome H. H. V. Custers;Wouter Koudstaal

  • A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer.

    Joseph Paul Eder;Philip W. Kantoff;Kristin Roper;GuangXian Xu

  • Phase I Study of Sequential Vaccinations With Fowlpox-CEA(6D)-TRICOM Alone and Sequentially With Vaccinia-CEA(6D)-TRICOM, With and Without Granulocyte-Macrophage Colony-Stimulating Factor, in Patients With Carcinoembryonic Antigen–Expressing Carcinomas

    John L. Marshall;James L. Gulley;Philip M. Arlen;Patricia K. Beetham

  • Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin.

    Dennis Panicali;Stephen W. Davis;Randall L. Weinberg;Enzo Paoletti

  • A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer.

    Philip M Arlen;James L Gulley;Catherine Parker;Lisa Skarupa

  • Recombinant pox virus for immunization against tumor-associated antigens

    Jeffrey Schlom;Judith Kantor;Donald Kufe;Dennis Panicali

  • Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen.

    Michael Wang;Vincenzo Bronte;Pauline W. Chen;Linda Gritz

  • Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients.

    Elke Jäger;Julia Karbach;Sacha Gnjatic;Antje Neumann

  • Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer.

    James Gulley;Alice P. Chen;William Dahut;Philip M. Arlen

  • Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer.

    Martin G. Sanda;Martin G. Sanda;David C. Smith;Linda G. Charles;Clara Hwang

  • Identification of NY-ESO-1 Peptide Analogues Capable of Improved Stimulation of Tumor-Reactive CTL

    J L Chen;P R Dunbar;U Gileadi;E Jäger

  • HIV-1-specific cytotoxic T lymphocyte responses in the first year of life.

    K Luzuriaga;D Holmes;A Hereema;J Wong

  • Molecular genetics of vaccinia virus: demonstration of marker rescue

    Eileen Nakano;Dennis Panicali;Enzo Paoletti

  • Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector.

    Rene Bernards;Antoinette Destree;Sara McKenzie;Ethel Gordon

  • Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma

    Howard L. Kaufman;Gail DeRaffele;Josephine Mitcham;Dorota Moroziewicz

  • Granulocyte/macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant

    Erik Kass;Dennis L. Panicali;Gail Mazzara;Jeffrey Schlom

Frequent Co-Authors

Norman L. Letvin
Norman L. Letvin Beth Israel Deaconess Medical Center
Jeffrey Schlom
Jeffrey Schlom National Institutes of Health
James L. Gulley
James L. Gulley National Institutes of Health
John L. Sullivan
John L. Sullivan University of Massachusetts Chan Medical School
Philip M. Arlen
Philip M. Arlen National Institutes of Health
Kwong Y. Tsang
Kwong Y. Tsang National Institutes of Health
Sampa Santra
Sampa Santra Beth Israel Deaconess Medical Center
David C. Montefiori
David C. Montefiori Duke University
Gary J. Nabel
Gary J. Nabel ModeX Therapeutics
Enzo Paoletti
Enzo Paoletti Rensselaer Polytechnic Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare career paths, many of which can be pursued through flexible online programs. For those looking to enter nursing without prior experience, exploring online adn programs for non nurses can be an excellent starting point. These programs provide foundational skills essential for patient care and immunology-related fields.

For quicker entry into the nursing profession, accelerated routes like the easiest absn program to get into offer a streamlined path for individuals who already hold a degree in another discipline. This option allows for fast-tracking essential nursing education without sacrificing quality.

Additionally, those seeking practical nursing roles may find that exploring which lpn programs are easiest to get into provides valuable insight into accessible programs that can lead to rewarding careers supporting immunology-related healthcare services.

For advanced practice and leadership in immunology and healthcare, many turn to easiest online nurse practitioner programs. These flexible degrees allow professionals to specialize further, often focusing on immunology, infectious diseases, or related fields, enhancing career growth and impact.

Best Scientists Citing Dennis Panicali

Recently Published Articles